The International Technology Transfer Institute (ITTI) at Franklin Pierce Law Center aims to foster innovation in developing countries through several activities: - Conducting scholarly research on issues related to intellectual property management, technology transfer, and access to information. - Organizing workshops, meetings, and conferences to engage with partners like WIPO. - Producing patent landscape reports on important health and agriculture innovations to improve access in developing areas. - Involving students through a clinical program to contribute to ITTI programs and reports. - Exploring partnerships and capacity building opportunities in countries like Colombia, Vietnam, Botswana, Zimbabwe, Nigeria, and others.

1. 1
ITTI: Building IP Capacity
Advancing Global Innovation
Stanley P. Kowalski
Director ITTI
Franklin Pierce Law Center
Concord, NH U.S.A.

2. 2
Recently, Pierce Law
launched the International
Technology Transfer
Institute (ITTI). ITTI provides
knowledge, educational and
networking resources to
build sustainable capacity in
IP management, technology
transfer and information
access.

3. 3
The International Technology Transfer
Institute (ITTI) is dedicated to fostering
innovation in developing countries.

4. 4
ITTI Faculty: Professors Cavicchi,
Hersey, Orcutt and Dr. Kowalski

5. 5
ITTI Mission PI/SJ: Developing country access to appropriate and
critical innovations in health and agriculture …
vaccines for tropical and neglected diseases, insect resistant crops
for sub-Saharan Africa, as well as identification of potentially
valuable biodiversity (e.g., algal strains as bio-fuel resources for
commercial production).

6. 6
The mission of ITTI is firmly rooted in the time-
honored tradition of the Franklin Pierce Law Center,
integrating scholarship, practice, education and
outreach into a comprehensive program that seeks
to promote social justice and advance the global
public interest. Alleviating suffering caused by
poverty, hunger and disease is the foundation of
social justice.

7. 7
The first essential
component for social
justice is adequate food
for all mankind.
Public-Private
Partnerships are needed
to share research and
development costs for
“pro-poor” biotechnology.
Professor Norman Borlaug
1970 Nobel Peace Prize,
Presidential Medal of Freedom,
Congressional Gold Medal
Recipient

8. 8
ITTI implements its mission via:
scholarly research and publication,
in-country activities including meetings,
workshops, lectures and conferences (several with
WIPO),
patent landscape analyses of innovations in health
and agriculture, and
a clinical program which engages student
contribution to ITTI programs.

9. 9
Patent landscape reports have included:
insect resistant sweet potato for Sub-
Saharan Africa,
HIV vaccines, and
novel biofuel resources and
technologies.
Access to Information Drives Innovation

10. 10
Patent landscape reports are completed in 15 weeks, i.e. in one semester.

11. 11
ITTI Patent Landscape Clinic: HIV DNA Vaccine Patent
Landscape: Aureka ThemeMap

12. 12
Patent landscape reports are conducted by Pierce Law
student teams, comprising both J.D. and graduate students
from diverse and international backgrounds.

13. 13
ITTI is completing a
comprehensive study of the law,
science and technology policy,
higher education, finance and
business infrastructures in India
and China to assess the
potential of developing public-
private partnerships that will
produce economic benefit from
publicly-funded research in
universities and research
institutes.

14. 14
Pierce Law also made significant contributions
to the recently published IP Management in
Health and Agricultural Innovation: A
Handbook of Best Practices.

15. 15
The IP Handbook addresses IP
management issues and
approaches within the context
of accelerating developing
country access to critical
innovations in health and
agriculture.

16. 16
ITTI Activities in
conjunction with external
organizations

17. 17
ITTI Activities in
conjunction with external organizations:
Forging dynamic, strategic linkages to
advance global innovation, foster
international development

18. 18

19. 19

20. 20

21. 21
ITTI Activities in
conjunction with WIPO

22. 22
Intellectual Property
Management Strategies
to Accelerate the
Development and Access of
Vaccines and Diagnostics:
Case Studies on Pandemic
Influenza, Malaria and SARS
Meeting hosted by WIPO,
the World Intellectual
Property Organization,
Geneva, Switzerland, April
2006

23. 23
Singapore-WIPO Regional Workshop on Patent Information –
September 8 and 9, 2009

24. 24
INTERNATIONAL CONVENTION ON INTELLECTUAL PROPERTY
AND COMPETITIVENESS OF MICRO, SMALL AND
MEDIUM-SIZED ENTERPRISES (MSMES)
ROME, ITALY, DECEMBER 9-11, 2009

25. ITTI Discussions with
World Bank Science,
Technology and
Innovation Group

26. World Bank, Washington D.C.,
March 25, 2010

27. ITTI Country-based
Project Development

28. 28
Colombia UMNG site visit and TTO concept note
Vietnam IBT VAST interest in TTO project
Botswana Survey of needs analysis for IP capacity
Zimbabwe Strategic Concept Note
Nigeria Expressed interest in IP capacity building

29. 29
ITTI UMNG Colombia Visit, November 20, 2008

30. 30
“We are very much interested to work with
you to push the technology transfer system
in Nigeria in line with Government
aspirations to develop this great country.”
Engr Umar B. Bindir PhD
Director General/CEO
National Office for Technology Acquisition and Promotion (NOTAP)
Federal Republic of Nigeria

31. 31
ITTI is currently working with several
public and private partners to engage in
technology transfer training and
capacity building in Argentina.

32. 32
ITTI is currently exploring other
opportunities to engage in
technology transfer training and
capacity building in China.

33. 33
Product Delivery is Essential:
Examples of innovations (inventions)
applicable to needs of developing
countries (inclusive) but subject to
potential IP rights (i.e. patents/patent
applications).

34. 34
1. Golden Rice
2. Parasitic Roundworm Vaccine
3. Phytoremediation of Dioxin
4. Red Detect Landmine Detection
System

35. 35
Gt1p psy (phytoene synthase) nos (ter)
35S (ter) aphIV (Hygromycin R) 35S (pro)
LB RB
35S (pro) tp crtI (phytoene desaturase) nos(ter)
pGt1psyH
psy (phytoene synthase)
pCPsyH
Daffodil cDNA
Gt1p
pKS1
Rice glutelin
promoter
pCIB900
pYPIET4
35S (pro) tp crtI (phytoene desaturase)nos(ter)
pSNIF83
Pea RuBisCo
transit peptide
pCRT-1
Erwinia uredovorapBI121
pBin19hpc
nos(ter)

36. 36

37. 37

38. 38

39. 39
Who are our clients?
Foundations?
Developing country
governments/universities?
Developing country technology transfer/IP
managers?

40. 40